​

Rachel Roberts  - KCIA (Kentucky Cannabis Industry Alliance)

As executive director of KCIA, Rep. Roberts will spearhead initiatives to unify and advocate for Kentucky’s cannabis industry stakeholders. Her leadership is expected to play a pivotal role in shaping policies that promote growth, sustainability, and social responsibility within the industry. Roberts emphasizes the significance of Senate Bill 47, stating, “The passage of Senate Bill 47 is a monumental step forward for Kentucky. This legislation will provide patients with access to much-needed medication to combat devastating illnesses, offering relief and improving quality of life for countless individuals across the Commonwealth."

 

 

 

 

 

Sam Flynn - Executive Director for the Kentucky Medical Cannabis Program

On June 1, 2023, the Governor appointed Sam Flynn as Executive Director for the Kentucky Medical Cannabis Program and Special Advisor to the Governor. Mr. Flynn will oversee the creation, design, and implementation of the Kentucky Medical Cannabis Program.

 

 

 

 

 

 

 

 

 

 

 

​Dr. Shanna Babalonis - Director of the UK Cannabis Center

Dr. Babaloinis has several active NIH grants to examine cannabis-opioid interactions and cannabis effects in those with opioid use disorder. Along with Dr. Walsh, she authored an updated report for the World Health Organization on cannabidiol (CBD) and presented the findings to the Expert Committee on Drug Dependence in Geneva, Switzerland. She is the Scientist Representative on the Council for Governmental Relations Hemp and Cannabis Group and serves on the Program Committee for the International Cannabinoid Research Society. She is also a consulting editor for the scientific journal, Cannabis. Dr. Babalonis provides physician education through Grand Rounds and lectures to physicians in the state on the risks and benefits of medical cannabis and has also given numerous presentations to residents, medical/dental students, and the public on cannabis-related topics.